Manute
@nuk96.bsky.social
📣 Excited to share our last work about clinical outcomes of patients treated with CAZAVI + ATM for VIM-P. aeruginosa infections, published in Journal of Antimicrobial Chemotherapy. Really grateful to all co-authors!
track.smtpsendmail.com/9032119/c?p=...
track.smtpsendmail.com/9032119/c?p=...
Ceftazidime-avibactam plus aztreonam cocktail for the treatment of VIM-producing Pseudomonas aeruginosa infections: good enough to have another?
AbstractBackground. Few active antibiotic options are available to treat MBL-producing Pseudomonas aeruginosa infections, and some of these options are eit
track.smtpsendmail.com
March 19, 2025 at 11:26 PM
📣 Excited to share our last work about clinical outcomes of patients treated with CAZAVI + ATM for VIM-P. aeruginosa infections, published in Journal of Antimicrobial Chemotherapy. Really grateful to all co-authors!
track.smtpsendmail.com/9032119/c?p=...
track.smtpsendmail.com/9032119/c?p=...